Clinical Trial Update: Anecortave Acetate Versus Placebo in AMD Patients Following PDT [Phase 2]

View source ↗

Summary

Phase 2 trial comparing anecortave acetate to placebo in age-related macular degeneration patients after photodynamic therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Alcon Research | Conditions: AMD | Phase 2 | Status: COMPLETED